Joshua Fuqua

Dr. Joshua Fuqua


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2015 in Plant Biotechnology Journal
Verified
Journal Article
Open access
PDF file
JFJoshua Fuqua
Joshua Fuqua
KHKrystal Hamorsky
Krystal Hamorsky
GKGuruatma Khalsa
Guruatma Khalsa
NMNobuyuki Matoba
Nobuyuki Matoba
KPKenneth E. Palmer
Kenneth E. Palmer
Summary: Application of plant‐based protein expression systems for bulk production of recombinant protein pharmaceuticals is building momentum. There are considerable regulatory challenges to consider in commercialization of plant‐made pharmaceuticals (PMPs), some of which are inherent to plant‐production systems and others that are common with other production systems, but are new to PMPs because of the youth of the industry. In this review, we discuss our recent and ongoing experience with bulk production of the HIV microbicide candidate, griffithsin (GRFT), utilizing plant‐based transient protein expression, with specific focus on areas relevant to commercial manufacturing of bulk GRFT active pharmaceutical ingredient (API). Analytical programs have been developed for the qualification and monitoring of both the expression vector system and the API detailing our experience and plans for each. Monitoring postpurification protein modifications are discussed in relation to stability and safety programs. Expression, processing and analytics programs are associated with increased manufacturing costs in current good manufacturing practice (cGMP) production because of the required qualification testing. The impact of these costs on the overall cost of goods is particularly relevant to GRFT manufacturing because GRFT, as an HIV microbicide, is most needed in populations at high risk for HIV exposure in resource‐poor countries. Consequently, GRFT for microbicide applications is a very cost‐sensitive recombinant PMP. We have therefore emphasized maintaining a low cost of goods. We provide a review of the literature on the economics of PMPs with various expression systems and how they may impact production costs and complexity.

22 February 2015 in BMC Biotechnology
Verified
Journal Article
Open access
PDF file
JFJoshua Fuqua
Joshua Fuqua
VWValentine Wanga
Valentine Wanga
KPKenneth E. Palmer
Kenneth E. Palmer
Griffithsin is a broad spectrum antiviral lectin that inhibits viral entry and maturation processes through binding clusters of oligomannose glycans on viral envelope glycoproteins. An efficient, scaleable manufacturing process for griffithsin active pharmaceutical ingredient (API) is essential for particularly cost-sensitive products such as griffithsin -based topical microbicides for HIV-1 prevention in resource poor settings. Our previously published purification method used ceramic filtration followed by two chromatography steps, resulting in a protein recovery of 30%. Our objective was to develop a scalable purification method for griffithsin expressed in Nicotiana benthamiana plants that would increase yield, reduce production costs, and simplify manufacturing techniques. Considering the future need to transfer griffithsin manufacturing technology to resource poor areas, we chose to focus modifying the purification process, paying particular attention to introducing simple, low-cost, and scalable procedures such as use of temperature, pH, ion concentration, and filtration to enhance product recovery. We achieved >99% pure griffithsin API by generating the initial green juice extract in pH 4 buffer, heating the extract to 55°C, incubating overnight with a bentonite MgCl2 mixture, and final purification with Capto™ multimodal chromatography. Griffithsin extracted with this protocol maintains activity comparable to griffithsin purified by the previously published method and we are able to recover a substantially higher yield: 88 ± 5% of griffithsin from the initial extract. The method was scaled to produce gram quantities of griffithsin with high yields, low endotoxin levels, and low purification costs maintained. The methodology developed to purify griffithsin introduces and develops multiple tools for purification of recombinant proteins from plants at an industrial scale. These tools allow for robust cost-effective production and purification of griffithsin. The methodology can be readily scaled to the bench top or industry and process components can be used for purification of additional proteins based on biophysical characteristics.

1 October 2021 in Pathogens
Verified
Journal Article
Open access
PDF file
EREric Rouchka
Eric Rouchka
JCJulia Chariker
Julia Chariker
KSKumar Saurabh
Kumar Saurabh
SWSabine Waigel
Sabine Waigel
WZWolfgang Zacharias
Wolfgang Zacharias
TSTed Smith
Ted Smith
Throughout the course of the ongoing SARS-CoV-2 pandemic there has been a need for approaches that enable rapid monitoring of public health using an unbiased and minimally invasive means. A major way this has been accomplished is through the regular assessment of wastewater samples by qRT-PCR to detect the prevalence of viral nucleic acid with respect to time and location. Further expansion of SARS-CoV-2 wastewater monitoring efforts to include the detection of variants of interest/concern through next-generation sequencing has enhanced the understanding of the SARS-CoV-2 outbreak. In this report, we detail the results of a collaborative effort between public health and metropolitan wastewater management authorities and the University of Louisville to monitor the SARS-CoV-2 pandemic through the monitoring of aggregate wastewater samples over a period of 28 weeks. Through the use of next-generation sequencing approaches the polymorphism signatures of Variants of Concern/Interest were evaluated to determine the likelihood of their prevalence within the community on the basis of their relative dominance within sequence datasets. Our data indicate that wastewater monitoring of water quality treatment centers and smaller neighborhood-scale catchment areas is a viable means by which the prevalence and genetic variation of SARS-CoV-2 within a metropolitan community of approximately one million individuals may be monitored, as our efforts detected the introduction and emergence of variants of concern in the city of Louisville. Importantly, these efforts confirm that regional emergence and spread of variants of interest/concern may be detected as readily in aggregate wastewater samples as compared to the individual wastewater sheds. Furthermore, the information gained from these efforts enabled targeted public health efforts including increased outreach to at-risk communities and the deployment of mobile or community-focused vaccination campaigns.

15 June 2020 in Journal of Biotechnology
Verified
Journal Article
Closed access
JCJulia M. Corman
Julia M. Corman
KHKrystal T. Hamorsky
Krystal T. Hamorsky
JSJohn W. Shepherd
John W. Shepherd
EHErnie Hiatt
Ernie Hiatt
JFJoshua Fuqua
Joshua Fuqua
KPKenneth E. Palmer
Kenneth E. Palmer

20 August 2021 in medRxiv
Verified
Preprint
Open access
PDF file
EREric Rouchka
Eric Rouchka
JCJulia L. Chariker
Julia L. Chariker
KSKumar Saurabh
Kumar Saurabh
SWSabine Waigel
Sabine Waigel
WZWolfgang Zacharias
Wolfgang Zacharias
TSTed Smith
Ted Smith
Throughout the course of the ongoing SARS-CoV-2 pandemic there has been a need for approaches that enable rapid monitoring of public health using an unbiased and minimally invasive means. A major way this has been accomplished is through the regular assessment of wastewater samples by qRT-PCR to detect the prevalence of viral nucleic acid with respect to time and location. Further expansion of SARS-CoV-2 wastewater monitoring efforts to include the detection of variants of interest / concern through next-generation sequencing have enhanced the understanding of the SARS-CoV-2 outbreak. In this report we detail the results of a collaborative effort between public health and metropolitan wastewater management authorities and the University of Louisville to monitor the SARS-CoV-2 pandemic through the monitoring of aggregate wastewater samples over a period of 28 weeks. Our data indicates that wastewater monitoring of water quality treatment centers and smaller neighborhood-scale catchment areas is a viable means by which the prevalence and genetic variation of SARS-CoV-2 within a metropolitan community of approximately one million individuals may be monitored. Importantly, these efforts confirm that regional emergence and spread of variants of interest / concern may be detected as readily in aggregate wastewater samples as compared to the individual wastewater sheds.

25 August 2020 in medRxiv
Verified
Preprint
Open access
PDF file
RYRay Yeager
Ray Yeager
RHRochelle Holm
Rochelle Holm
KSKumar Saurabh
Kumar Saurabh
JFJoshua Fuqua
Joshua Fuqua
DTDaymond Talley
Daymond Talley
TSTed Smith
Ted Smith
Background: Wastewater monitoring for virus infections within communities can complement conventional clinical surveillance. Currently, most SARS-CoV-2 testing is performed during clinical encounters with symptomatic individuals, and therefore likely underrepresents actual population prevalence. Randomized testing on a regular basis to estimate population-level infection rates is prohibitively costly and is hampered by a range of barriers associated with participation in clinical research. In comparison, community-level fecal monitoring can be performed through wastewater surveillance and can effectively surveil communities with less temporal lag than other surveillance methods. However, epidemiologically-defined protocols for wastewater sample site selection are lacking. Methods: Herein we describe methods for developing a geographically-resolved population-level wastewater sampling approach in Jefferson County, Kentucky which may have general applicability for cities throughout the United States. This approach was developed by the selection of sampling locations along sewer lines transporting raw wastewater from geographically and demographically distinct areas that correspond with locations where random testing of residents occurs. Conclusions: Development of this protocol for population-level sampling for SARS-CoV-2 prevalence in wastewater can be utilized to inform consistent wastewater monitoring among cities for up-to-date and geographically-resolved information on COVID-19 prevalence within communities. This information could substantially supplement public health surveillance of COVID-19 and thus serve to better guide targeted mitigation strategies throughout the United States.